Tau PET scan
Combination ProductPatient will receive a dose of flutaucipir and be scanned appropriately
NCT Number: NCT03618186
The researchers are trying to gather information and learn more about imaging tests in racially different people who are cognitively normal or have dementia.
Interested in participating?
Request Info30 year and older
All sexes
Interventional
Phase 2
Mayo Clinic in Florida, Jacksonville, Florida, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patient will receive a dose of flutaucipir and be scanned appropriately
Time frame: 5 years
Percentage of each of the three groups with tau positive scans
Mayo Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06245031
AD, Alzheimer Disease
Phoenix, Arizona, United States
View Trial DetailsNCT05637801
Alzheimer Disease, Alzheimer Disease 1
Gilbert, Arizona, United States
View Trial DetailsNCT07200739
Alzheimer Dementia (AD), Alzheimer Disease
Roskilde, Region Sjælland, Denmark
View Trial DetailsNCT06596746
Alzheimer Disease, Amyotrophic Lateral Sclerosis
Cassino, Frosinone, Italy
View Trial Details